Recent Statistical Developments in Bioequivalence Trials — A Review of the FDA Guidance*
- 1 July 1994
- journal article
- review article
- Published by Springer Nature in Drug Information Journal
- Vol. 28 (3) , 851-864
- https://doi.org/10.1177/009286159402800321
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- On the assessment of variability in bioavailability/bioequivalence studiesCommunications in Statistics - Theory and Methods, 1992
- Estimation of direct formulation effect under log‐normal distribution in bioavailability/bioequivalence studiesStatistics in Medicine, 1992
- Constructing Release Targets for Drug Products: A Bayesian Decision Theory ApproachJournal of the Royal Statistical Society Series C: Applied Statistics, 1991
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Outlier detection in bioavailability/bioequivalence studiesStatistics in Medicine, 1990
- Test for batch‐to‐batch variation in stability analysisStatistics in Medicine, 1989
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- An exact confidence interval from untransformed data for the ratio of two formulation meansJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Tables for An Approximate Test for Outliers in Linear ModelsTechnometrics, 1975
- Estimates of Location Based on Rank TestsThe Annals of Mathematical Statistics, 1963